Hongri Pharmaceutical: Net profit in 2024 was 51.052 million yuan, a year-on-year decrease of 89.92%.

Jinshi data news on February 27th, Hongri Pharmaceutical announced that the company’s total operating income in 2024 was 5.783 billion yuan, a year-on-year decrease of 5.34%; the net profit attributable to the shareholders of the listed company was 51.052 million yuan, a year-on-year decrease of 89.92%; the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 24.0792 million yuan, a year-on-year decrease of 93.59%; the basic earnings per share was 0.02 yuan, a year-on-year decrease of 88.24%; the weighted average return on net assets was 0.59%, a year-on-year decrease of 5.38%.